Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Benini

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Bioconjugate Chemistry|November 22, 2001
A novel approach to the high-specific-activity labeling of small peptides with the technetium-99m fragment [99mTc(N)(PXP)]2+ (PXP = diphosphine ligand)A Boschi, C Bolzati, E Benini, et al.
British Journal of Cancer|January 26, 2000
Biomarkers and outcome after tamoxifen treatment in node-positive breast cancers from elderly womenM G Daidone, A Luisi, G Martelli, et al.
Journal of the National Cancer Institute|June 16, 1993
p53 as an independent prognostic marker in lymph node-negative breast cancer patientsR Silvestrini, E Benini, M G Daidone, et al.
International Journal of Cancer|November 24, 1999
Biological markers as indicators of response to primary and adjuvant chemotherapy in breast cancerM G Daidone, S Veneroni, E Benini, et al.
Journal of the National Cancer Institute|April 6, 1994
The Bcl-2 protein: a prognostic indicator strongly related to p53 protein in lymph node-negative breast cancer patientsR Silvestrini, S Veneroni, M G Daidone, et al.
International Journal of Oncology|May 17, 2011
Biological markers in transurethral biopsies from bladder-cancer - preliminary-resultsE Benini, A Costa, G Pizzocaro, et al.
Journal of the National Cancer Institute|May 7, 1997
Expression of p53, glutathione S-transferase-pi, and Bcl-2 proteins and benefit from adjuvant radiotherapy in breast cancerR Silvestrini, S Veneroni, E Benini, et al.
Data in Brief|January 19, 2019
Normalized performance and load data for the deepwind demonstrator in controlled conditionsL Battisti, E Benini, A Brighenti, et al.
Cancer|January 15, 1998
The clinical predictivity of biomarkers of stage III-IV epithelial ovarian cancer in a prospective randomized treatment protocolR Silvestrini, M G Daidone, S Veneroni, et al.
International Journal of Cancer|May 4, 1995
Changes in biological markers after primary chemotherapy for breast cancersM G Daidone, R Silvestrini, A Luisi, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Bioconjugate Chemistry|November 22, 2001
A novel approach to the high-specific-activity labeling of small peptides with the technetium-99m fragment [99mTc(N)(PXP)]2+ (PXP = diphosphine ligand)A Boschi, C Bolzati, E Benini, et al.
British Journal of Cancer|January 26, 2000
Biomarkers and outcome after tamoxifen treatment in node-positive breast cancers from elderly womenM G Daidone, A Luisi, G Martelli, et al.
Journal of the National Cancer Institute|June 16, 1993
p53 as an independent prognostic marker in lymph node-negative breast cancer patientsR Silvestrini, E Benini, M G Daidone, et al.
International Journal of Cancer|November 24, 1999
Biological markers as indicators of response to primary and adjuvant chemotherapy in breast cancerM G Daidone, S Veneroni, E Benini, et al.
Journal of the National Cancer Institute|April 6, 1994
The Bcl-2 protein: a prognostic indicator strongly related to p53 protein in lymph node-negative breast cancer patientsR Silvestrini, S Veneroni, M G Daidone, et al.
International Journal of Oncology|May 17, 2011
Biological markers in transurethral biopsies from bladder-cancer - preliminary-resultsE Benini, A Costa, G Pizzocaro, et al.
Journal of the National Cancer Institute|May 7, 1997
Expression of p53, glutathione S-transferase-pi, and Bcl-2 proteins and benefit from adjuvant radiotherapy in breast cancerR Silvestrini, S Veneroni, E Benini, et al.
Data in Brief|January 19, 2019
Normalized performance and load data for the deepwind demonstrator in controlled conditionsL Battisti, E Benini, A Brighenti, et al.
Cancer|January 15, 1998
The clinical predictivity of biomarkers of stage III-IV epithelial ovarian cancer in a prospective randomized treatment protocolR Silvestrini, M G Daidone, S Veneroni, et al.
International Journal of Cancer|May 4, 1995
Changes in biological markers after primary chemotherapy for breast cancersM G Daidone, R Silvestrini, A Luisi, et al.
Pageof 4